Pioneering the World’s First Cannabis Extracts Marketplace Built on the Blockchain.
PRIVATE SALE FINISHES IN
WHAT ARE THE PROBLEMS?
enables transparency, price standardization and consumer confidence.
MORE ABOUT CANNABIUM
ONE Colombia officially registers its cannabis brand.2016
Planning starts for the tokenization of medicinal cannabis extracts via a decentralized exchange to create spot pricing.2017
Cannabium drafts its whitepaper, giving vision to the rise of a global, open and distributed platform for the exchange of medical cannabis extracts.
Software development underway to allow tokens denominated in non-crypto currencies during a token sale.
The two-phase token sale contract for Cannabium is deployed on the Ethereum network.
Cannabium sold to qualified participants in a private pre-sale.
Active development of the "Coinbridge," cross-blockchain services.2018
Planned identify additional production partners.
Planned start development of distribution capacity.2019
Planned: completion of token sale.
Issuance of Cannabium tokens.
Scheduled start of product delivery for cash sale settlement
The Cannabium marketplace is beta released
The Cannabium marketplace is live
ONE Colombia’s vision is to be the market leader for high-end cannabis derived APIs (Active Pharmaceutical Ingredients) and other high-quality cannabis extracts. They broke ground on the state-of-the-art extraction and purification facility in December 2017. With a production capacity of up to 150 tons of cannabis oil per year, ONE will be competitive in the global cannabis market while setting the standard for high quality and purity.
Token sales and terms
TOKEN SUPPLY: 738,000,000 CNAB TOKENS
No token additional
issuing is planned.
% Of Extra Coins
|PRIVATE - SALE||21/08/18 - 15/11/18||-||-|
|PRE - SALE||16/11/18 - 10/01/19||$5.5k*||45.5%|
|ICO STEP 1||11/01/19 - 18/01/19||$10*||33.3%|
|ICO STEP 2||19/01/19 - 26/01/19||$10*||23.1%|
|ICO STEP 3||27/01/19 - 03/02/19||$10*||14.3%|
|ICO STEP 4||04/02/19 - 11/02/19||$10*||6.7%|
|ICO FINAL $0.08||12/02/19 - 19/02/19||$10*||0%|
FUND RASING GOALS
Nachshol is a medicinal chemist with years of hands-on experience in cannabis extractions, downstream processing, product development on an industrial scale, and a proven record from seed to product. In addition, Nachshol is the founder of several biotech and cannabis ventures worldwide including Mycolivia Medicinal Mushrooms, Innova Biopharmaceuticals, and YieldTech, Ltd. Nachshol has over 15 years of experience in growing cannabis and has managed and advised industrial-scale operations serving companies like Israel Medicinal Cannabis (IMC) and other cannabis companies worldwide. He is an expert at the full process from breeding to harvesting and has developed novel QA/QC standards for the cannabis industry by utilizing the latest high-end sensing and visual processing capabilities.
Co-Founder, Cannabis Expert
As Founder and CEO of ONE Colombia, Cannabium’s primary production partner, Carlos has extensive experience of more than 15 years working in marketing network industry. He has managed to generate millions of dollars in monthly sales for the companies in which he has participated professionally. His dedication, commitment and interest in the benefits of the community has allowed him to consolidate his position as a recognized social leader. His great charisma and altruism arouses in others a great admiration and inspires them to achieve their own dreams and goals, following his clear example of personal improvement.
Alon has worked closely with thousands of people over two decades, aiming to help each and every one of them to make their lives better. He has been supporting people through healing processes and inspiring them to make a difference in their lives using alternative medicinal methods.
In the process of deepening his understanding of natural medicinal herbs, Alon was led to meeting Nachshol 6 years ago.
Through the years,Alon has been investing in people and projects that have the potential to make a real difference in the world, for the benefit of humanity.
President Shoval & Co.